Patents by Inventor Franco Gaetani

Franco Gaetani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9084812
    Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.
    Type: Grant
    Filed: May 23, 2014
    Date of Patent: July 21, 2015
    Assignee: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A
    Inventors: Franco Gaetani, Ashraf Virmani
  • Publication number: 20150045424
    Abstract: It is described the use of L-carnitine and/or an alkanoyl L-carnitine, or a pharmaceutically acceptable salt thereof, in combination with a statin, for the preparation of a medicament for the treatment of type 2 diabetes.
    Type: Application
    Filed: October 28, 2014
    Publication date: February 12, 2015
    Inventors: Franco GAETANI, Ashraf VIRMANI
  • Publication number: 20140255512
    Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.
    Type: Application
    Filed: May 23, 2014
    Publication date: September 11, 2014
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Franco GAETANI, Ashraf VIRMANI
  • Patent number: 8758835
    Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: June 24, 2014
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Franco Gaetani, Ashraf Virmani
  • Patent number: 8349317
    Abstract: Use of L-carnitine and/or one or more alkanoyl L-carnitines or one of their pharmaceutically acceptable salts for the preparation of a dietary supplement or medicament for the treatment of corneal diseases is disclosed.
    Type: Grant
    Filed: June 30, 2006
    Date of Patent: January 8, 2013
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite SpA
    Inventors: Franco Gaetani, Janos Feher
  • Patent number: 8252309
    Abstract: Dietary supplements—providing energy and strengthening skeletal muscles and facilitating skeletal muscles ability to sustain prolonged periods of physical activity—containing propionyl-L-carnitine or one of its salts, coenzyme Q10, nicotinamide, riboflavin, pantothenic acid and optionally other components such as amino acids and creatines.
    Type: Grant
    Filed: October 20, 2005
    Date of Patent: August 28, 2012
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite SpA
    Inventor: Franco Gaetani
  • Patent number: 8207109
    Abstract: A food supplement with a “slimming” effect is disclosed which strengthens the skeletal muscle, protecting the cardio-vascular apparatus of the user, and has as its characterising components propionyl L-carnitine, coenzyme Q10 nicotinamide, riboflavin and pantothenic acid.
    Type: Grant
    Filed: June 13, 2001
    Date of Patent: June 26, 2012
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite SpA
    Inventor: Franco Gaetani
  • Publication number: 20110262417
    Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.
    Type: Application
    Filed: July 24, 2009
    Publication date: October 27, 2011
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Franco Gaetani, Ashraf Virmani
  • Publication number: 20100034795
    Abstract: Use of L-carnitine and/or one or more alkanoyl L-carnitines or one of their pharmaceutically acceptable salts for the preparation of a dietary supplement or medicament for the treatment of corneal diseases is disclosed.
    Type: Application
    Filed: June 30, 2006
    Publication date: February 11, 2010
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE IUNITE S.P.A.
    Inventors: Franco Gaetani, Janos Feher
  • Publication number: 20100029759
    Abstract: It is described the use of L-canitine and/or an alkanoyl L-canitine, or a pharmaceutically acceptable salt thereof, in combination with a statin, for the preparation of a medicament for the treatment of type 2 diabetes.
    Type: Application
    Filed: November 20, 2007
    Publication date: February 4, 2010
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Franco Gaetani, Ashraf Virmani
  • Publication number: 20090257996
    Abstract: Dietary supplements—providing energy and strengthening skeletal muscles and facilitating skeletal muscles ability to sustain prolonged periods of physical activity—containing propionyl-L-carnitine or one of its salts, coenzyme Q10, nicotinamide, riboflavin, pantothenic acid and optionally other components such as amino acids and creatines.
    Type: Application
    Filed: September 20, 2006
    Publication date: October 15, 2009
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventor: Franco Gaetani
  • Publication number: 20060057188
    Abstract: Dietary supplements—providing energy and strengthening skeletal muscles and facilitating skeletal muscles ability to sustain prolonged periods of physical activity—containing propionyl-L-carnitine or one of its salts, coenzyme Q10, nicotinamide, riboflavin, pantothenic acid and optionally other components such as amino acids and creatines.
    Type: Application
    Filed: October 20, 2005
    Publication date: March 16, 2006
    Inventor: Franco Gaetani
  • Publication number: 20050249713
    Abstract: Dietary supplements—providing energy and strengthening skeletal muscles and facilitating skeletal muscles ability to sustain prolonged periods of physical activity—containing propionyl-L-carnitine or one of its salts, coenzyme Q10, nicotinamide, riboflavin, pantothenic acid and optionally other components such as amino acids and creatines.
    Type: Application
    Filed: July 6, 2005
    Publication date: November 10, 2005
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventor: Franco Gaetani
  • Publication number: 20040058947
    Abstract: A composition is disclosed which, depending on the user, may take the form of a health food or a medicine, comprising a combination of the following as its characterising components: (a) L-carnitine inner salt or one of its pharmacologically acceptable salts; (b) acetyl L-carnitine inner salt or one of its pharmacologically acceptable salts; and (c) huperzine A or huperzine B or mixtures thereof or extracts of Huperzia serrata containing them, suitable for the prevention/treatment of learning disorders in children suffering form Attention Deficit/Hyperactive Disorder (ADHD).
    Type: Application
    Filed: July 1, 2003
    Publication date: March 25, 2004
    Inventor: Franco Gaetani
  • Publication number: 20040028668
    Abstract: A food supplement with a “slimming” effect is disclosed which strengthens the skeletal muscle, protecting the cardio-vascular apparatus of the user, and has as its characterising components propionyl L-carnitine, coenzyme Q10 nicotinamide, riboflavin and pantothenic acid.
    Type: Application
    Filed: July 1, 2003
    Publication date: February 12, 2004
    Inventor: Franco Gaetani
  • Publication number: 20030129177
    Abstract: A dietary supplement is disclosed which supplies the skeletal muscle with energy and protects the cardiovascular tract, the characterising components of which comprise propionyl L-carnitine, coenzyme Q10, nicotinamide, riboflavin and pantothenic acid.
    Type: Application
    Filed: January 14, 2003
    Publication date: July 10, 2003
    Applicant: Sigma-Tau HealthScience S.p.A.
    Inventor: Franco Gaetani
  • Publication number: 20030003091
    Abstract: A dietary supplement is disclosed which supplies the skeletal muscle with energy and protects the cardiovascular tract, the characterising components of which comprise propionyl L-carnitine, coenzyme Q10, nicotinamide, riboflavin and pantothenic acid.
    Type: Application
    Filed: December 3, 2001
    Publication date: January 2, 2003
    Inventor: Franco Gaetani